In Vivo Evaluation of Dual-Targeted Nanoparticles Encapsulating Paclitaxel and Everolimus

A synergistic combination of paclitaxel (PTX) and everolimus (EVER) can allow for lower drug doses, reducing the toxicities associated with PTX, while maintaining therapeutic efficacy. Polymeric nanoparticles (NPs) of high stability provide opportunities to modify the toxicity profile of the drugs b...

Descripción completa

Detalles Bibliográficos
Autores principales: Houdaihed, Loujin, Evans, James Christopher, Allen, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628352/
https://www.ncbi.nlm.nih.gov/pubmed/31146485
http://dx.doi.org/10.3390/cancers11060752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628352/
https://www.ncbi.nlm.nih.gov/pubmed/31146485
http://dx.doi.org/10.3390/cancers11060752

Ejemplares similares